Search Results
Site Search
Updated Test Promises Fewer False Positives in Newborn Screening for Krabbe Disease - Insights
Mayo Clinic’s Biochemical Genetics Laboratory has announced an updated second-tier test to detect Krabbe disease (KD) that uses psychosine (PSY) as a disease marker. The new test method has significantly higher sensitivity to detect this...
CPT Codes and LOINC Update: June 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of June 2019.
Infectious diseases - Insights
Mayo Clinic BioPharma Diagnostics offers access to the clinical trial infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our...
Vector-borne diseases - Insights
Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.
This featured section focuses on events, updates, and items of interest for Mayo Clinic Laboratories’ clients, health care providers, lab staff, and the public.
Skip to Content MayoACCESS MayoLINK...
Week in Review Archives - Insights
Skip to Content MayoACCESS MayoLINK...
National Stop The Bleed Day - Insights
Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, talks about the importance of National Stop The Bleed Day, a national awareness campaign about the top cause of preventable death in trauma.
Staffing to Workload in Phlebotomy Areas: Off-Site Operational Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on off-site operational needs, including paid time off and unpaid time off.
Balancing work, family, and personal life can be very challenging for employees. Dawn Doherty, Education Program Coordinator at Mayo Clinic, highlights the importance of employee wellness and identifies resources that may be helpful in your...
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
History of Mayo Clinic School of Graduate Medical Education #ThrowbackThursdays - Insights
Ever since Mayo Clinic was established, the institution's goal has been to provide outstanding care to its patients and offer superior education programs that ensure the success of the next generation of medical professionals. Read more...
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Mayo Clinic was named the best hospital in the nation in U.S. News & World Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the...
CPT Codes and LOINC Update: Jan. 2019 - Insights
The list of updates posted to mayocliniclabs.com during the month of January 2019 are now available.
CPT Codes and LOINC Update: May 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of May 2019.
What's Next in Precision Medicine: Moving New Discoveries into Daily Clinical Care - Insights
Experts in individualized medicine—the concept of shaping health care based on lifestyle, environment, and genetic code—will be in Rochester September 12–13 to present how the newest discoveries can be applied to personalized health care.
Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education.
Week in Review: October 4 - Insights
Top highlights include: Flu vaccine information, possible effects that red meat has on the human body, and what vaping does to the lungs.
Mayo Clinic Laboratory and pathology research roundup: November 15 - Insights
This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors
Mayo Clinic Laboratory and Pathology Research Roundup: July 10 - Insights
This week’s Research Roundup highlights the association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
Researchers at Mayo Clinic have identified a possible cause for a rare infection in heart and lung transplant recipients: the donor.
1907: The First Plummer Project #ThrowbackThursday - Insights
The successful launch of Epic at Mayo Clinic Health System sites in Wisconsin on July 8 recalls another milestone 110 years ago. On July 19, 1907, patient No. 1 registered in the new system designed by Henry Plummer, M.D., in collaboration...
1863: Mayo and the Military #ThrowbackThursday - Insights
In May 1863, while the Battle of Chancellorsville was raging in Virginia and shortly before the climactic Battle of Gettysburg in Pennsylvania, an English-born, Minnesota-based physician named William Worrall Mayo, M.D., signed an oath of...
1879: Calling Dr. Mayo #ThrowbackThursday - Insights
May marks the fifth anniversary of the Mayo Clinic app—hailed by tech specialists and consumers alike as “what every patient app should be.” But Mayo’s leadership in telephone communications dates back much farther.
Mayo Clinic Laboratory and pathology research roundup: December 14 - Insights
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
September 2020 — Clinical Microbiology, Hematology, Hematopathology, & Infectious Disease - Insights
This "Pathways" program provides a Anatomic and Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology, Hematology, Hematopathology, and...
March 2023 - Breast Pathology Case 1 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance...
Testing Archives - Page 20 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
A downward spiral undone: Jon Bratsch - Insights
Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...
Against the odds: Alex Kraatz - Insights
As a two-time brain tumor survivor, Alex Kraatz has been through more harrowing medical experiences in his 34 years than most people face in a lifetime. But Alex’s fighting spirit, coupled with precision laboratory testing and cutting-edge...
The Living Breast Biobank - Insights
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
How digital pathology provides faster answers - Insights
Almost four years ago, Mayo Clinic launched the Digital Pathology Program, a major pathology initiative. Phase 2 of this multi-phase rollout has recently been completed, which involved the implementation of cutting-edge digital equipment...
Leveraging technology to transform Anatomic Pathology - Insights
As Mayo Clinic’s Anatomic Pathology moves from traditional glass slides to digital images, the advance in technology is achieving clear benefits in collaboration, learning, and patient care.
Kootenai Health: Recapturing their market through precision coordination - Insights
Prevented from providing testing services to its community members due to a non-compete agreement with a national laboratory, Kootenai Health laboratory leaders deepened their relationship with Mayo Clinic Laboratories, receiving tactical...
Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros - Insights
One summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t...
Revolutionizing Endometrial Cancer Diagnostics - Insights
Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...
Infectious diseases - Insights
Mayo Clinic offers a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Developed through evidence-driven clinical innovation and designed to deliver clarity on drug and alcohol use, our testing delivers results that advance understanding and improve outcomes.
Relentless innovation - Insights
Inspired by Mayo Clinic’s history of breaking down barriers to change medicine, we are constantly reimagining what’s possible in diagnostics.
Glimmer of Hope: Gregor Heinrich - Insights
While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the...
Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights
An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...
June 2023 - Neuropathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Neuropathology.
MCL @Work: Michael Goard - Insights
More than 17 years ago, Michael Goard started his career at Mayo Clinic in Specimen Operations. Today, he takes great pride in his role as a field service manager working with clients and making a difference for our patients.